APA (7th ed.) Citation

JY, H., YT, L., CH, H., TS, L., CY, L., SF, Y., & MY, L. (2026). Risk of peripheral vestibular disorders and hearing impairment among users of glucagon-like peptide-1 receptor agonists. International journal of medical sciences, 23(4), 1577. https://doi.org/10.7150/ijms.131397

Chicago Style (17th ed.) Citation

JY, Huang, Lu YT, Hsin CH, Lo TS, Lee CY, Yang SF, and Liao MY. "Risk of Peripheral Vestibular Disorders and Hearing Impairment Among Users of Glucagon-like Peptide-1 Receptor Agonists." International Journal of Medical Sciences 23, no. 4 (2026): 1577. https://doi.org/10.7150/ijms.131397.

MLA (9th ed.) Citation

JY, Huang, et al. "Risk of Peripheral Vestibular Disorders and Hearing Impairment Among Users of Glucagon-like Peptide-1 Receptor Agonists." International Journal of Medical Sciences, vol. 23, no. 4, 2026, p. 1577, https://doi.org/10.7150/ijms.131397.